Than, Ngu Wah 
ORCID: 0000-0003-4991-5431, Pritchard, D Mark ORCID: 0000-0001-7971-3561, Hughes, David M ORCID: 0000-0002-1287-9994, Duckworth, CA ORCID: 0000-0001-7971-3561, Wong, H, Ul Haq, Muneeb, Sripadam, R and Myint, Arthur Sun
(2024)
Sequence of Contact X-ray Brachytherapy (CXB) and External Beam Radiation (EBRT) in organ-preserving treatment for small rectal cancer
Radiotherapy and Oncology, 199.
p. 110465.
ISSN 0167-8140, 1879-0887
Abstract
Background and purpose: External Beam Radiotherapy (EBRT) followed by Contact X-ray Brachytherapy (CXB) and vice versa are viable alternatives to surgery for selected rectal cancer patients who have small tumours (≤3 cm). However, the optimal sequence of treatment needs to be established. We compared two approaches using Propensity Score (PS) matching and inverse probability treatment weighting (IPTW) analyses to investigate whether the sequence of treatment affected patient outcomes. Materials and methods: This retrospective analysis (2008–2019) included patients with rectal adenocarcinoma (cT1-3,N0-1,M0, grade 1–2, size ≤ 3 cm) who received both EBRT and CXB, irrespective of treatment sequence. PS matching and IPTW were conducted to balance covariate standardised mean differences between groups. Oncological outcomes and rate of post-treatment rectal bleeding were assessed. Results: Following PS matching and IPTW analyses from 251 eligible patients; 103 starting with EBRT (median follow-up: 37 [IQR:18–56] months) and 148 with CXB (median follow-up: 32 [IQR:16–54] months, a significant improvement in 3-year overall survival (77% vs 85%, p = 0.02, [HR:0.58 (95% CI:0.37–0.91)]) and a higher risk of post-treatment rectal bleeding (grade 1 (26%) and grade 2 (6%)) were found in patients who started with CXB (p = 0.08). No significant differences were observed in local regrowth (18% vs 12%, p = 0.47), distant relapse (10% vs 6%, p = 0.53), 3-year organ preservation rates (70% vs 75%, p = 0.20, [HR:0.66 (95% CI: 0.35–1.26)]), or disease-free survival (78% vs 82%, p = 0.17, [HR: 0.47 (95% CI: 0.16–1.38)]) Conclusion: In patients with rectal cancer (≤3 cm), commencing with CXB rather than EBRT, was associated with improved overall survival, but had a higher risk of G1/2 rectal bleeding. No statistically significant differences were observed in other oncological outcomes.
| Item Type: | Article |
|---|---|
| Additional Information: | Source info: RADONC-D-24-00291 |
| Uncontrolled Keywords: | Humans, Adenocarcinoma, Rectal Neoplasms, Brachytherapy, Retrospective Studies, Aged, Aged, 80 and over, Middle Aged, Female, Male, Propensity Score, Organ Sparing Treatments |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 01 Aug 2024 07:26 |
| Last Modified: | 22 Jan 2026 06:42 |
| DOI: | 10.1016/j.radonc.2024.110465 |
| Open Access URL: | https://www.thegreenjournal.com/article/S0167-8140... |
| Related Websites: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3183266 |
| Disclaimer: | The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate. |
Altmetric
Altmetric